STOCK TITAN

UTHR (NASDAQ: UTHR) insider files to sell 50 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of UTHR has filed a Rule 144 notice to sell 50 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ. The filing lists an aggregate market value of $23,711.50 for these shares and shows 43,056,599 shares outstanding.

The shares to be sold were acquired as restricted stock from the issuer on 06/26/2025. Over the past three months, the same seller reported four prior sales of 50 shares each, with gross proceeds of $25,606.00, $24,149.00, $23,049.00, and $24,750.50.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Form 144 filing for UTHR disclose?

The Form 144 filing for UTHR discloses an insider’s intent to sell 50 shares of common stock on NASDAQ. The shares have an aggregate market value of $23,711.50 and were acquired as restricted stock from the issuer on 06/26/2025.

How many UTHR shares are planned to be sold and through which broker?

The filing states that 50 UTHR common shares are planned to be sold. The transaction is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located in New York, with the shares listed for trading on the NASDAQ exchange.

What prior UTHR share sales has this insider reported in the last three months?

Over the last three months, the insider reported four separate sales of 50 UTHR common shares each. These occurred on 12/11/2025, 12/23/2025, 01/06/2026, and 01/20/2026, with gross proceeds ranging from $23,049.00 to $25,606.00.

How many UTHR shares are outstanding according to this Form 144?

The Form 144 indicates that there are 43,056,599 shares of UTHR common stock outstanding. This figure provides context for the planned 50-share Rule 144 sale, showing the relative size of the insider’s transaction compared with total outstanding shares.

How were the UTHR shares in this Form 144 acquired by the insider?

The filing shows the 50 UTHR common shares to be sold were acquired on 06/26/2025 as restricted stock directly from the issuer. The date of payment is also listed as 06/26/2025, and the nature of payment is described as Not Applicable.
United Therapeutics Corp.

NASDAQ:UTHR

View UTHR Stock Overview

UTHR Rankings

UTHR Latest News

UTHR Latest SEC Filings

UTHR Stock Data

22.98B
42.93M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SILVER SPRING